Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of DDT mRNA] | affects expression|affects reaction | 19414516
|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of DDT mRNA] | affects expression|affects reaction | 19414516
|
D000242 |
Cyclic AMP |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of DDT mRNA] | affects expression|affects reaction | 19414516
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of DDT protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DDT mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DDT mRNA | decreases expression | 20106945
|
C032036 |
bromobenzene |
bromobenzene metabolite binds to DDT protein | affects binding | 17305373
|
D003345 |
Corticosterone |
Corticosterone results in increased expression of DDT mRNA | increases expression | 15755911
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of DDT mRNA | decreases expression | 20106945
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of DDT mRNA | decreases expression | 18035473
|
C056933 |
fumonisin B1 |
fumonisin B1 results in decreased expression of DDT mRNA | decreases expression | 16221962
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DDT mRNA | affects cotreatment|increases expression | 17183730
|
C029424 |
hydrazine |
hydrazine results in decreased expression of DDT protein | decreases expression | 15370871
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DDT mRNA | increases expression | 16221962 18301758
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DDT mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.57 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.98 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.00 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.68 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.56 | 16434500 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.62 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 17688650 17507914 18177632 18985861 18775368 15238991 17157402 18558336 18396377 20603192 16609825 19232924 18940202 19460635 18316065 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.10 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.20 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.43 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.03 | 20146248 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.96 | 12907637 21507988 12619106 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.06 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.56 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.89 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.89 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.89 | 8888407 17688650 16575769 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
6.63 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
6.63 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.63 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.11 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.53 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.23 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.01 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.96 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.63 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.37 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.15 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.02 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.39 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.39 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.39 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.98 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.19 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.21 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.68 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.57 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
9.01 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.01 | 16221962 19176532 19772884 18467677 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.95 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.12 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.70 | 16612254 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.67 | 17296493 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.66 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.37 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.78 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.16 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.51 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.51 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.51 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.77 | 8603461 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.36 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.43 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.43 | 20135361 20064080 18569708 17053015 6695378 18520028 18816296 20869020 20464547 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
3.66 | 12807724 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.23 | 18765137 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
5.22 | 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.08 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.18 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.16 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.99 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.90 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.90 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.16 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.27 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.91 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.96 | 17292933 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.64 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.41 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.23 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.77 | 11738929 11044598 15475178 3137016 17978042 1511512 16876388 14763951 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.39 | 10029692 19755658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.82 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.64 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.33 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.60 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.20 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.71 | 8888407 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |